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Background: A number of studies have shown an association between health-related quality of life (HRQL) and
socioeconomic status (SES). Indicators of SES usually serve as potential confounders; associations between SES and
HRQL are rarely discussed in their own right. Also, few studies assess the association between HRQL and SES among
those with a chronic disease. The study focuses on the question of whether people with the same state of health
judge their HRQL differently according to their SES, and whether a bias could be introduced by ignoring these
differences.
Methods: The analyses were based on a representative sample of the adult population in Germany (n = 11,177).
HRQL was assessed by the EQ-5D-3 L, i.e. the five domains (e.g. ‘moderate or severe problems’ concerning mobility)
and the Visual Analog Scale (VAS). SES was primarily assessed by educational level; age, sex and family status were
included as potential confounders. Six chronic diseases were selected, each having a prevalence of at least 1%
(e.g. diabetes mellitus). Multivariate analyses were conducted by logistic and linear regression.
Results: Among adults with a chronic disease, most ‘moderate or severe problems’ are reported more often in the
low (compared with the high) educational group. The same social differences are seen for VAS values, also in
subgroups characterized by ‘moderate or severe problems’. Gender-specific analyses show that for women the
associations with VAS values can just be seen in the total sample. For men, however, they are also present in
subgroups defined by ‘moderate or severe problems’ or by the presence of a chronic disease; some of these
differences exceed 10 points on the VAS scale.
Conclusions: Low SES groups seem to be faced with a double burden: first, increased levels of health impairments
and, second, lower levels of valuated HRQL once health is impaired. These associations should be analysed and
discussed in their own right, based on interdisciplinary co-operation. Social epidemiologists could include measures
of HRQL in their studies more often, for example, and health economists could consider assessing whether
recommendations based on HRQL scales might include a social bias.
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Health-related quality of life (HRQL) is often assessed
by the EuroQol 5D (using here the version with three
problem levels, EQ-5D-3 L). The EQ-5D-3 L has been
translated into many languages and applied to numerous
health problems (more than 3,900 publications are cur-
rently listed on the homepage) [1]. Associations with so-
cioeconomic status (SES) are reported in a number of
them, but they are rarely discussed in their own right.
Indicators of SES (e.g. educational level) usually serve as
potential confounders, and some studies do not even
mention the associations between SES and HRQL, al-
though they are reported in the tables. Another reason
for including SES is to demonstrate the construct valid-
ity of the instrument for assessing HRQL, but associa-
tions between SES and HRQL are an important topic
per se. Concerning research focusing on health inequal-
ities, it has to be asked whether these inequalities are
underestimated if HRQL is not included in the analyses.
Concerning research focusing on quality of life, it has to
be asked whether people with the same state of health
judge their HRQL differently according to their SES, and
whether this could lead to a social bias introduced by
assessing HRQL with an instrument such as the EQ-5D-
3 L. However, these questions are rarely addressed [2].
Three groups of analyses can be differentiated: (a) stud-
ies looking at differences in HRQL by SES in a sample of
the general population; (b) studies reporting these associa-
tions after controlling for risk factors and for chronic dis-
eases; and (c) studies showing these associations among
those with a chronic disease. Most papers belong to the
first group, and they often use the EQ-5D-3 L to assess
HRQL. They come, for example, from the USA [3-6],
New Zealand [7], Japan [8], China [9], the UK [10-13],
Sweden [14], Spain [15,16], Greece [17,18], Denmark
[19,20] and the Netherlands [21]; some studies combine
data from different Western European countries [22-24].
Of course they also differ in the way the sample was
drawn, but despite these differences they consistently
show that HRQL increases with increasing SES, in terms
of problems reported [9,12,19-21,23,24] and in terms of
overall HRQL assessment [3-6,10,13,14,16,17,22].
There are also a number of papers looking at the asso-
ciation between SES and HRQL after controlling for risk
factors and chronic diseases (second group), and again
most of them have assessed HRQL using the EQ-5D-
3 L. They are based on survey data from the general
population, controlling, for example, for risk factors such
as obesity and smoking [25], for self-reported diabetes
[26], for the presence of any chronic disease [2], for a se-
lection of different chronic diseases [27-30] or for a
number of chronic diseases [31-33]. The studies come
from the USA and Canada [26,27,32,33], the UK [25,31],
Sweden [28], Finland [29] and Germany [2,30]. Andagain, despite differing countries and samples, they con-
sistently show that low SES is associated with low HRQL
even after controlling for these risk factors and chronic
diseases, in terms of both problems reported [2,28] and
overall HRQL assessment [25-27,29-33].
Thus, the basic association between SES and HRQL
seems to be well established and undisputed (i.e. HRQL
is especially low in the low SES groups, in the total
population and also in analyses adjusting for some risk
factors or chronic diseases). The third group of analyses
is more interesting, however. If the same association be-
tween SES and HRQL could also be found among pa-
tients with diabetes mellitus, for example, this would
clearly indicate two potential problems: health inequal-
ities would be underestimated if HRQL is not assessed,
and policy recommendations based on HRQL analyses
could be biased if the differences according to SES are
not stressed. Although not primarily devoted to the in-
vestigation of SES, most of these studies include SES in
the analysis of HRQL, looking at a specific group of pa-
tients such as patients with heart attack [34], myocardial
infarction [35], type 2 diabetes [36], chronic low back pain
[37], chronic obstructive pulmonary disease (COPD) [38],
depression [39] or patients undergoing elective cardiac
surgery [40] or percutaneous coronary intervention (PCI)
[41]. Other studies are based on population surveys in-
cluding different chronic diseases [33,42,43]. Again, HRQL
is mostly assessed using the EQ-5D-3 L. The associations
with SES are often reported in simple bivariate analyses,
and the results are contradictory. Some report that the
positive association between SES and HRQL is significant
either for men or for women or for specific indicators of
SES [37]. Others show that this association is significant
only for the EQ-5D-3 L time trade-off (TTO) valuation,
but not for the EQ-5D-3 L Visual Analog Scale (VAS)
[40]. Some indicate that this association is not statistically
significant [39], and some do not even include a statistical
test for this association [33,42].
In this third group, the association between SES and
HRQL does not become any clearer in analyses control-
ling for other variables such as age. Jerant et al. [44] ana-
lysed data from chronically ill adults enrolled in a self-
management intervention, and they found no significant
association between educational level and EQ-5D-3 L
summary index. Lacey and Walters [34] analysed data
from patients who had a heart attack, assessing HRQL
using EQ-5D-3 L and SF-36. Concerning EQ-5D-3 L,
they found that HRQL (summary index) is lower in the
low SES group, but the 5% level of statistical significance
was clearly missed. Concerning SF-36, a significant asso-
ciation with SES could just be found for two domains
(i.e. bodily pain and vitality). Miravitlles et al. [38] ana-
lysed data from patients with COPD. The results show
that low educational level is associated with low HRQL
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was assessed by occupational status. Schweikert et al.
[35] analysed data from patients with myocardial infarc-
tion (MI), and Wexler et al. [36] analysed data from pa-
tients with type 2 diabetes. They both found that HRQL
(summary index) was significantly lower in the low SES
group. Stafford et al. [43] published an analysis based on
survey data, including a number of different chronic dis-
eases. Using the EQ-5D-3 L (summary index), they
found that the reduction in HRQL resulting from hyper-
tension or diabetes was significantly greater in the low
compared with the high SES group, and that this associ-
ation could not be found for angina, heart attack or
stroke. But again, in these analyses, SES is mostly in-
cluded as a confounder, and the associations between
SES and HRQL are not discussed in any detail.
We would argue that the association between SES and
HRQL among patients with a chronic disease is an im-
portant topic in its own right, and to date little is known
about it. It has rarely been addressed, and the available
studies show mixed and sometimes contradictory results.
In order to support this discussion, the objective of our
study is to add a detailed analysis from Germany, testing
the hypothesis that HRQL is not especially low in low
SES groups, in the total population or in subgroups of
the population defined by a chronic disease.
Methods
The HRQL questions have been included in a yearly repre-
sentative survey of the German adult population, con-
ducted by the ‘Wort & Bild Verlag’ 2006–2011. The sample
was drawn based on a random selection of households and
from one person over 14 years of age per household. The
overall response rate was about 73% [2]. In order to ac-
count for potential selection bias, a weighting factor based
on the distribution of age and sex has been included in all
analyses to ensure representativeness. Each survey com-
prises about 2,000 individuals aged 14 years or above. The
analyses were restricted to participants who were at least
20 years of age, as school education (our main independent
variable) should be finished by this age. The surveys com-
prise a face-to-face interview and a self-administered ques-
tionnaire for the EQ-5D-3 L. Previous publications based
on other parts of these data describe the distribution of
HRQL in Germany [45] and the basic associations with
educational level [2]. The data have also been used to de-
velop a new method estimating a value set for the EQ-5D-
3 L based on health states experienced [46].
Concerning studies on health inequalities in Germany,
educational level is widely accepted to be the most im-
portant indicator of SES, mainly for two reasons: Educa-
tional level is crucial for future occupation, and
educational level rarely changes after 20 years of age. The
German educational system is quite complicated and itdiffers between the 16 German states. The main charac-
teristics are: (a) three levels of school (in German:
Hauptschule, Mittlere Reife, Abitur) with the highest level
(i.e. ‘Abitur’ with a standard duration of 12 or 13 years)
qualifying for the university, and (b) three levels of voca-
tional training: no vocational training, blue collar, white
collar (e.g. with university degree). The distribution in the
population strongly depends on the age group under
study. The percentage of adults with the lowest level of
school (i.e. ‘Hauptschule’) is steadily decreasing. Our study
focuses on adults with a mean age of about 50 years. The
statistical report for Germany states that in this age group
the percentage with ‘Hauptschule’ is about 40%, whereas it
is just about 20% in the age group 25–35 years [47]. In
our study, educational level was assessed by a single ques-
tion, primarily assessing the highest level of school educa-
tion (i.e. adding hardly any information on vocational
training). This is why we focused on school education, dif-
ferentiating between ‘low’ (i.e. ‘Hauptschule’) and ‘high’
(i.e. ‘Mittlere Reife’ or ‘Abitur’). The percentage of partici-
pants with ‘Hauptschule’ is quite high, but the German
school system does not allow for a narrower definition of
low SES. It is difficult to fit the German educational sys-
tem into the International Standard Classification of Edu-
cation (ISCED). A substantial effort has been made, for
example, in an international study concerning genetic var-
iants associated with educational attainment [48]; finally
‘Hauptschule’ has been categorized as ISCED 2 or 3.
Additional analyses were carried out with monthly
per-capita income instead of educational level, differenti-
ating between five groups each including about 20% of
the sample; finally, ‘low income’ (quintiles 1 and 2) was
compared with ‘high income’ (quintiles 4 and 5). The
dataset also includes three other sociodemographic vari-
ables, i.e. nationality, family status and employment sta-
tus. Concerning nationality, more than 98% of the
participants reported ‘German’. This is why nationality
has not been controlled for in further analyses. Two
groups of family status could be differentiated, i.e. living
with a partner and living without a partner (68.42% resp.
31.58%). Employment status was assessed by six categor-
ies: (a) full-time or part-time employed (53.01%); (b) not
employed due to military or civil service, maternity leave
(0.87%); (c) temporary unemployed (4.46%); (d) pen-
sioner (30.62%); (e) not employed due to housekeeping
(e.g. housewife) (7.28%); (f ) not employed due to voca-
tional training, occupational re-training (3.76%). Some
studies show an association between lack of paid em-
ployment and low HRQL, again most of them using the
EQ-5D-3 L [23,49,50]. In our study, lack of paid employ-
ment was defined by combining the last four categories
mentioned above (comprising 46.99% of the sample).
Concerning morbidity, the participants were asked
whether they had a chronic disease, and we selected
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problems with the musculoskeletal system, hypertension,
diabetes mellitus, heart disease, rheumatism, headache
or migraine). In order to assess multi-morbidity, we in-
cluded two more variables: first, ‘any of these six chronic
diseases’ and, second, ‘any chronic disease’ (these six dis-
eases plus other chronic diseases such as arthrosis,
asthma, dermatosis or gastro-intestinal disease).
The dependent variables are provided by both parts of
the EQ-5D-3 L, with the first part including five domains
(i.e. mobility, self-care, usual activities, pain/discomfort,
anxiety/depression) with three potential answers each (i.e.
no, moderate or severe problems), and the second part
using the Visual Analog Scale (VAS). Logistic regression is
used for dichotomous dependent variables (i.e. the pres-
ence of moderate or severe problems), and linear regres-
sion for the continuous dependent variable (i.e. VAS),
with other variables (e.g. age and sex) included as poten-
tial confounders. All analyses were conducted with the
software package SAS ® version 9.1 (SAS Institute Inc.,
Cary, NC, USA).
Results
The basic distribution of the variables is shown in
Table 1. The dataset includes information from 11,177
people over 20 years of age with a slightly higher propor-
tion of women (52.5%), reflecting their longer life ex-
pectancy. Many respondents belong to the low
educational group (44%), a distribution always seen for
adults in Germany [47]. Looking at the five dimensions
of the EQ-5D-3 L, the prevalence of moderate or severe
problems is highest for pain/discomfort and lowest for
self-care. The prevalence of moderate or severe prob-
lems is higher for women than for men, though some of
these differences are rather small. Concerning the six
chronic diseases selected for further analyses, a signifi-
cantly higher prevalence for women can just be seen for
headache/migraine. The differences according to educa-
tional level are much clearer: moderate or severe prob-
lems are always considerably and significantly higher in
the low compared with the high educational group, and
the same picture is seen for just about all chronic disease
variables.
The distribution of the VAS values is shown in Table 2.
The overall value is 80.0; it decreases considerably if mod-
erate or severe problems concerning mobility etc. are re-
ported or chronic diseases. Looking at the total sample,
the value for men is higher than that for women, and the
same differences can be seen in most subgroups defined
by moderate or severe problems in at least one of the
five domains. No significant differences between men
and women could be found in the subgroups defined by
chronic disease. The differences according to educa-
tional level are clear and consistent: low educationallevel is always associated with lower VAS values (in the
total sample and in all subgroups).
Additional analyses (not shown in the table) looked at
the associations from a different perspective, i.e. at the
prevalence of chronic diseases by educational level in
the subgroup not reporting any problems at all, a health
state denoted ‘11111’ in the EQ-5D-3 L terminology. In
this subgroup, the prevalence of ‘any of the six chronic
diseases’ investigated in detail (see Table 1) is signifi-
cantly higher in the low compared with the high educa-
tional group (8.13% versus 4.50%; p < 0.001). The same
picture can also be seen for the prevalence of ‘any
chronic disease’ (11.59% versus 7.78%; p < 0.001). Owing
to reduced sample size by health states, this type of ana-
lysis was possible only for the subgroup denoted ‘11111’,
but the results show that, among respondents not
reporting any problem at all, the prevalence of chronic
disease increases with SES.
The first group of multivariate analyses is based on the
dependent variables ‘moderate or severe problems in the
five domains of the EQ-5D-3 L’. Six multivariate analyses
referring to the five problem domains of the EQ-5D-3 L
or to the occurrence of at least one of them have been
conducted for every group of participants (total sample,
plus eight groups defined by ‘chronic disease’), and each
model is adjusted for age and sex. The odds ratios for
age and sex (not shown in the table) illustrate that most
of these problems increase significantly with age (the
only exception being anxiety/depression) and that most
of these problems are significantly more common among
women than among men (the only exception being pain/
discomfort). The odds ratios for low compared with high
educational level are shown in Table 3. Looking first at the
total sample, moderate or severe problems concerning
mobility are significantly higher for those with a low edu-
cational level, and the same is true concerning the other
four domains. In the next step, the same association is
tested for subgroups defined by the presence of a chronic
disease. Among those with diabetes mellitus, for example,
moderate or severe problems concerning mobility, self-
care, usual activities and anxiety/depression are signifi-
cantly more common for those with a low educational
level. Similar differences according to educational level are
seen for all chronic disease groups except rheumatism.
Analysing these associations separately for men and
women, most results are replicated, but some differences
in health impact linked to educational level can be
highlighted (not shown in the table). Relative to women,
men with a low educational level have substantially higher
odds of incurring ‘moderate to severe problems’ concern-
ing self-care in five disease groups (musculoskeletal sys-
tem, diabetes mellitus, heart disease, any of the six chronic
diseases, any chronic disease). In contrast, women with a
low educational level have substantially higher odds of
Table 1 Prevalence of ‘moderate/severe problems’ and of chronic disease
Sex Educational level
Men Women Low High
n % n % n % n %
Total sample 5,305 47.5 5,872 52.5 4,927 44.0 6,250 56.0
Problemsa concerning:
Mobility 709 13.4 958 16.3* 1,127 22.9 540 8.7*
Self-care 202 3.8 267 4.5 346 7.0 123 2.0*
Usual activities 567 10.7 756 12.9* 913 18.6 410 6.6*
Pain/discomfort 1,735 32.8 2,116 36.1* 2,264 46.0 1,586 25.4*
Anxiety/depression 449 8.5 930 15.9* 764 15.6 615 9.7*
At least 1 dimension 1,903 36.1 2,454 42.0* 2,477 50.7 1,881 30.3*
None of theseb 3,363 63.9 3,387 58.0* 2,413 49.4 4,336 69.8*
Chronic diseasec
Muscul. system 381 7.2 426 7.3 487 9.9 320 5.1*
Hypertension 355 6.7 431 7.3 491 10.0 295 4.7*
Diabetes mellitus 198 3.7 236 4.0 291 5.9 142 2.3*
Heart disease 152 2.9 139 2.4 196 4.0 96 1.5*
Rheumatism 110 2.1 130 2.2 160 3.3 80 1.3*
Headache/migraine 59 1.1 169 2.9* 115 2.3 114 1.8
Any of these sixd 972 18.3 1,156 19.7 1,283 26.1 844 13.5*
Any chronic diseasee 1,298 24.5 1,675 28.5* 1,699 34.5 1,275 20.4*
*p < 0.05 (chi2 test comparing men/women resp. low/high educational level).
a)Moderate or severe problems; missing values: mobility (n = 17), self-care (n = 24), usual activities (n = 19), pain/discomfort (n = 22), anxiety/depression (n = 29).
b)None of these problems.
c)Selection of chronic diseases with an overall prevalence of n ≥2% (ordered by prevalence).
d)At least one of the six chronic diseases listed above.
e)Any chronic disease (these six plus other chronic diseases such as arthrosis, asthma, dermatosis or gastro-intestinal disease).
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bility, usual activities and pain/discomfort in the group
with headache or migraine.
In further analyses (not shown in table), educational
level was replaced by per-capita income. The results are
very similar as compared to those shown in Table 3, but
the associations are somewhat weaker; just nine signifi-
cant odds ratios (5% level) can be found in the six dis-
ease groups (as compared to 13 significant odds ratios
seen in Table 3). A similar picture is seen if educational
level is replaced by employment status. Concerning
problems with ‘usual activities’, for example, lack of paid
employment is associated with significant odds ratios in
four disease groups (problems with musculoskeletal sys-
tem: 3.27; diabetes mellitus: 3.50; heart disease: 6.02;
headache/migraine: 6.09). In other analyses we included
family status and employment status as independent var-
iables. In the initial model with educational level as the
dependent variable (see Table 3), most significant odds
ratios remained significant at the 5% level (for example
all significant odds ratios concerning problems with
‘usual activities’). Also, including family status and em-
ployment status hardly changed the odds ratios for per-capita income, and including family status hardly chan-
ged the odds ratios for lack of paid employment.
The second group of multivariate analyses considers
the overall valuation of health. Table 4 presents the asso-
ciation between educational level and VAS values in dif-
ferent subgroups. Three multivariate analyses (men,
women, both combined) have been conducted for every
group of participants (total sample, plus seven groups
defined by ‘problems’ and eight groups defined by
‘chronic disease’) and each model is adjusted for age.
The VAS values are significantly lower in the low (com-
pared with the high) educational group, for both men
and women, but the difference is smaller for women
(−1.84) than for men (−2.98). In the combined sample,
this difference is also found for the subgroups defined by
problem dimension (the only exception being usual ac-
tivities) and by disease (the only clear exception being
‘musculoskeletal system’). For men, these associations
can also be seen for the same subgroups defined by
problem dimension and by disease. Some of these differ-
ences are pronounced, reaching more than 10 points on
the VAS scale (i.e. moderate or severe problems con-
cerning self-care; presence of diabetes mellitus, heart
Table 2 Mean VAS values in subgroups of participants with ‘moderate/severe problems’ or with chronic disease
VAS value (mean)
N Overall Sex Educational level
Men Women Low High
Total sample 11,177 80.0 81.1 79.0* 75.3 83.7*
Problemsa concerning:
Mobility 1,667 56.2 57.1 55.6 54.5 59.7*
Self-care 468 50.0 53.6 47.2* 47.2 57.7*
Usual activities 1,323 53.6 55.3 52.4* 52.3 56.7*
Pain/discomfort 3,850 64.9 65.6 64.3* 62.7 68.1*
Anxiety/depression 1,379 61.3 59.5 62.2* 57.6 65.9*
At least 1 dimension 4,358 66.3 66.6 66.0 63.7 69.7*
None of these 6,749 88.9 89.4 88.4* 87.3 89.8*
Chronic diseasea
Muscul. system 807 63.9 65.0 62.8 62.2 66.3*
Hypertension 786 63.2 63.7 62.8 60.9 67.0*
Diabetes mellitus 433 58.8 58.6 59.0 55.6 65.6*
Heart disease 292 57.0 56.7 57.4 54.8 61.6*
Rheumatism 240 59.3 60.8 58.0 57.0 64.0*
Headache/migraine 228 74.2 73.6 74.5 69.2 79.3*
Any of these six 2,128 64.5 64.5 64.5 61.8 68.6*
Any chronic disease 2,973 65.2 65.4 65.1 62.4 69.0*
*p < 0.05 (t-test comparing men/women resp. low/high educational level).
a)see Table 1.
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no significant differences could be found between low
and high educational level in any subgroup.
In further analyses (not shown in table), educational
level was replaced by per-capita income. Low income is
associated with lower VAS values, in the total sample,
both among men and women. In the subgroups defined
by ‘problems’ and by ‘chronic disease’, though, the sex
specific results are quite different from those presented
in Table 4: For educational level, the associations are
mainly restricted to men (Table 4), for income, though,
they are mainly restricted to women. The pattern does
not change that much if educational level is replaced by
employment status, i.e. lack of paid employment is asso-
ciated with lower VAS values, and in the subgroups
defined by ‘problems’ and by ‘chronic disease’ this differ-
ences is mainly found among men. In other analyses we
included family status and employment status as inde-
pendent variables. In the initial model with educational
level as the dependent variable most significant odds ra-
tios (see Table 4) remained significant. Also, including
family status and employment status hardly changed the
odds ratios for per-capita income, and including family
status hardly changed the odds ratios for lack of paid
employment.Discussion
The main results can be summarized in the following
way: (a) Most ‘moderate or severe problems’ are re-
ported more often in the low (compared with the high)
educational group. This association can also be seen in
multivariate analyses (e.g. controlling for age and sex)
among adults with a chronic disease such as diabetes
mellitus. (b) The VAS values are significantly lower in
the low (compared with the high) educational group
and also in subgroups defined by ‘moderate or severe
problems’ or by the presence of a chronic disease. For
men, the same picture can be seen in multivariate ana-
lyses (controlling for age), and some of these differ-
ences exceed 10 points on the VAS scale. For women,
these associations were found only overall, but not at
subgroup level. Given these results, the study hypoth-
esis ‘no differences in HRQL according to SES in sub-
groups of the population defined by a chronic disease’
must clearly be rejected.
Some limitations need to be considered. The study is re-
stricted to adults who are able to read and understand
German. All information is based on self-report, including
the information on chronic disease. It would be better to
have subjective and objective measures of morbidity, but
self-reported information does not have to be a major
Table 3 Multivariate association between educational level and ‘moderate/severe problems’: participants with a
chronic disease
Odds ratio (p-value) for low educational level a
Moderate or severe problems concerning …
Mobility Self-care Usual activities Pain/discomf. Anxiety/depression At least 1 dimension
Total sample 1.56* 1.87* 1.72* 1.45* 1.22* 1.39*
(<0.0001) (<0.0001) (<0.0001) (<0.0001) (0.0012) (<0.0001)
Chron. diseaseb
Muscul. 1.30 2.11* 1.63* 0.95 1.10 0.81
System (0.0998) (0.0072) (0.0038) (0.8340) (0.5968) (0.4364)
Hypertension 1.02 1.49 1.53* 1.26 0.97 1.37
(0.8887) (0.1642) (0.0170) (0.1773) (0.8862) (0.0798)
Diabetes 1.58* 2.15* 2.26* 1.00 2.24* 1.47
Mellitus (0.0484) (0.0329) (0.0007) (0.9994) (0.0018) (0.1730)
Heart disease 1.93* 3.18* 2.05* 1.83* 1.48 1.77
(0.0181) (0.0031) (0.0077) (0.0464) (0.1707) (0.0824)
Rheumatism 1.72 1.72 1.55 2.15 1.21 2.09
(0.0692) (0.2001) (0.1530) (0.0843) (0.5512) (0.1963)
Headache/ 1.91 2.28 3.04* 2.04* 1.73 1.79
Migraine (0.0712) (0.1777) (0.0101) (0.0488) (0.1403) (0.1157)
Any of 1.39* 2.36* 1.72* 1.32* 1.20 1.31*
These six (0.0012) (<0.0001) (<0.0001) (0.0132) (0.0957) (0.0235)
Any chronic 1.49* 2.07* 1.61* 1.31* 1.25* 1.28*
Disease (<0.0001) (<0.0001) (<0.0001) (0.0028) (0.0145) (0.0120)
*Significant at the 5% level.
a)Comparison group ‘high educational level’, adjusted for age and sex.
b)See Table 1.
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http://www.hqlo.com/content/12/1/58problem. It has repeatedly been shown, for example, that
self-assessed health is a good predictor even for mortality
[51,52]. Multiple testing could be an issue. Table 3, for ex-
ample, comprises results from 54 different multivariate
analyses. Following the Bonferroni correction, the p-value
would have to be divided by the number of tests con-
ducted (i.e. a p-value of about .001 would have to be used
instead of .05). Just few p-values are smaller than .001, but
such correction might be too conservative, as we would
assume that the six models per disease group are not inde-
pendent from each other (problems concerning ‘mobility’
could be associated with problems concerning ‘self care’,
for example). Therefore, we do not report respectively cor-
rected results, but we acknowledge that results will need
confirmation in future research. The importance of the
paper’s contribution lies in detailing educational impact
on quality of life over a broad spectrum of morbidity; ra-
ther than elaborating on a specific chronic disease or on a
specific ‘problem’ such as mobility. Educational impact is
analysed across several groups of adults with different
chronic diseases and health problems.
It has already been stressed above that there are few
studies analysing the association between SES and HRQLfor adults with a specific chronic disease, and that they
show mixed results (see Introduction). Concerning multi-
variate analyses controlling for age and sex, we were able
to identify just three studies reporting significant associa-
tions between SES and HRQL. Focusing on myocardial in-
farction survivors in Germany, Schweikert et al. [35]
found that low educational level is associated with low
HRQL (as assessed by the EQ-5D-3 L summary score).
The same association was reported by Wexler et al. [36]
in their study on patients with type 2 diabetes in the USA,
assessing HRQL using the Health Utilities Index-III.
Stafford et al. [43] analysed data from the Health Survey
for England and showed that the reduction in HRQL (as
assessed by the EQ-5D-3 L summary score) resulting from
obesity, hypertension or diabetes was significantly greater
in the group with low (compared with high) occupational
status. We believe that our study extends this scarce evi-
dence in several important ways. First, this study is not
based on a clinical population, but on a large representa-
tive population survey. Second, different subgroups of
‘moderate/severe problems’ and of chronic diseases were
analysed and compared based on the same methods
of sampling and disease identification. Third and most
Table 4 Multivariate association between educational level and mean VAS score: participants with ‘moderate/severe
problems’ or with chronic disease
Linear regression coeff. for low educational level a
Men women Total b
Estimate P-value Estimate P-value Estimate P-value
Total – 2.98* <0.0001 −1.84* <0.0001 −2.57* <0.0001
Problemsc concerning:
Mobility – 4.11* 0.0064 −1.07 0.4683 −2.52* 0.0171
Self-care −10.29* 0.0042 −2.25 0.4537 −5.69* 0.0134
Usual activities – 3.06 0.0896 −0.60 0.7143 −1.72 0.1548
Pain/discomfort – 2.86* 0.0020 −0.61 0.4821 −1.77* 0.0052
Anxiety/depression – 5.00* 0.0116 −1.90 0.1643 −3.00* 0.0076
At least 1 dimension – 2.92* 0.0007 −1.02 0.1920 −1.97* 0.0007
None of these – 0.73* 0.0404 −0.43 0.2293 −0.58* 0.0218
Chronic diseasec
Muscul. system – 0.82 0.6778 +0.26 0.8938 −0.24 0.8610
Hypertension – 4.81* 0.0231 −0.65 0.7406 −2.74 0.0563
Diabetes mellitus −10.14* 0.0006 −5.14 0.0533 −7.37* 0.0002
Heart disease −10.53* 0.0092 −1.70 0.6290 −5.53* 0.0429
Rheumatism – 7.18* 0.0345 −2.93 0.4447 −4.96 0.0532
Headache/migraine −10.23* 0.0012 −3.73 0.1933 −5.54* 0.0151
Any of these six – 4.74* 0.0002 −1.44 0.2197 −3.10* 0.0003
Any chronic disease – 3.45* 0.0019 −0.86 0.3790 −2.15* 0.0034
*Significant at the 5% level.
a)Comparison group: ‘high educational level’; adjusted for age.
b)Also adjusted for sex.
c)See Table 1.
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differences in HRQL according to SES can also be found
among patients with six specific chronic diseases. In most
of the studies mentioned above, SES is included as a con-
founder, and differences by SES are a ‘by-product’ not dis-
cussed in any detail.
Conclusions
The study indicates that HRQL and SES may be signifi-
cantly associated, and that health inequalities are misre-
presented if HRQL is not taken into account. Low SES
groups seem to be faced with a double burden: first, in-
creased levels of health impairments and, second, lower
levels of valuated HRQL once health is impaired. We
would conclude that all studies of HRQL in patients
with chronic disease should consider measures of SES,
that associations between HRQL and SES should be ana-
lysed separately for men and women, and that these as-
sociations should be discussed in their own right and
be considered in interpretation. Questions for future
research include the development of approaches to ex-
plain why patients with low SES valuate their HRQL to
be worse than patients with high SES, given the samechronic disease. To improve public health, it is import-
ant to develop and evaluate approaches aimed at redu-
cing the impact of SES on HRQL, such as preventive or
health-promoting measures targeted especially at groups
with low SES.
Interdisciplinary co-operation may support work on
the above research questions and the understanding of
the relation between HRQL and SES. To give just one
example, social epidemiology provides expertise con-
cerning the analysis of interactions between SES and
health, and health economics brings in expertise in valu-
ing health and in measuring the impact of interventions
[53]. The relation between SES and HRQL may also play
a role in health care decision making. Following Dolan
et al. [54], most people agree that potential gains in
HRQL could be ‘sacrificed’ for potential reductions in
inequalities. Trade-offs between efficiency and equity
linked to specific health care interventions remain to be
quantified in future studies. For groups of chronically ill
patients, this study shows that SES and HRQL are asso-
ciated, and thus informs decision makers that the health
impacts of interventions for the chronically ill may incur
equity aspects.
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